Open Label Immunotherapy Trial for Ovarian Cancer
NCT03556566
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Ovarian Cancer
Interventions
BIOLOGICAL:
Tableted vaccine (V3-OVA) containing ovarian cancer antigens
Sponsor
Immunitor LLC